CN1238770A - 为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物 - Google Patents

为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物 Download PDF

Info

Publication number
CN1238770A
CN1238770A CN97199602A CN97199602A CN1238770A CN 1238770 A CN1238770 A CN 1238770A CN 97199602 A CN97199602 A CN 97199602A CN 97199602 A CN97199602 A CN 97199602A CN 1238770 A CN1238770 A CN 1238770A
Authority
CN
China
Prior art keywords
compound
alkyl
formula
tumor cells
title compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97199602A
Other languages
English (en)
Chinese (zh)
Inventor
F·G·乔罗格
R·J·多尔
S·W·雷米斯泽维斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1238770A publication Critical patent/CN1238770A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN97199602A 1996-09-13 1997-09-11 为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物 Pending CN1238770A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US71298996A 1996-09-13 1996-09-13
US87740097A 1997-06-17 1997-06-17
US08/712,989 1997-06-17
US08/877,400 1997-06-17

Publications (1)

Publication Number Publication Date
CN1238770A true CN1238770A (zh) 1999-12-15

Family

ID=27108923

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97199602A Pending CN1238770A (zh) 1996-09-13 1997-09-11 为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物

Country Status (12)

Country Link
EP (1) EP0929544B1 (https=)
JP (1) JP2001521489A (https=)
KR (1) KR20000036111A (https=)
CN (1) CN1238770A (https=)
AT (1) ATE282036T1 (https=)
AU (1) AU4801197A (https=)
CA (1) CA2266015C (https=)
DE (1) DE69731544T2 (https=)
ES (1) ES2229340T3 (https=)
HU (1) HUP0001109A2 (https=)
IL (1) IL128931A0 (https=)
WO (1) WO1998011092A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549072A (zh) * 2020-04-23 2021-10-26 鲁南制药集团股份有限公司 一种托法替布杂质ⅰ的制备方法

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5925639A (en) * 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
HUP0003048A2 (hu) * 1997-06-17 2001-06-28 Schering Corp. Farnezil-protein transzferáz gátlására alkalmazható benzo[5,6]ciklohepta[1,2-b]piridin-származékok
US5852034A (en) * 1997-06-17 1998-12-22 Schering Corporation Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
NZ501617A (en) * 1997-06-17 2001-09-28 Schering Corp 4-(5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine derivatives useful for inhibition of farnesyl protein transferase
US6218401B1 (en) 1997-06-17 2001-04-17 Schering Corporation Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2331999A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2318088A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
ATE274498T1 (de) * 1998-07-24 2004-09-15 Russinsky Ltd Verfahren zur herstellung von benzocycloheptapyridin-11-one
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6262216B1 (en) 1998-10-13 2001-07-17 Affymetrix, Inc. Functionalized silicon compounds and methods for their synthesis and use
WO2001098268A2 (en) 2000-06-21 2001-12-27 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
SI1556358T1 (sl) * 2002-10-03 2007-10-31 Schering Corp Enantioselektivna alkilacija tricikličnih spojin
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2004046111A1 (en) * 2002-11-18 2004-06-03 Schering Corporation 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2005017160A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
EP1695961A4 (en) * 2003-12-17 2007-10-24 Takeda Pharmaceutical UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
JP2007529555A (ja) * 2004-03-18 2007-10-25 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド シヌクレイノパチーを治療する方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
KR920014799A (ko) * 1991-01-18 1992-08-25 나오가따 다이도 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
CA2174105C (en) * 1993-10-15 2002-02-12 W. Robert Bishop Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5721236A (en) * 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
IL125062A (en) * 1995-12-22 2003-11-23 Schering Corp Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549072A (zh) * 2020-04-23 2021-10-26 鲁南制药集团股份有限公司 一种托法替布杂质ⅰ的制备方法
CN113549072B (zh) * 2020-04-23 2024-12-06 鲁南制药集团股份有限公司 一种托法替布杂质ⅰ的制备方法

Also Published As

Publication number Publication date
IL128931A0 (en) 2000-02-17
ES2229340T3 (es) 2005-04-16
CA2266015A1 (en) 1998-03-19
DE69731544D1 (de) 2004-12-16
HUP0001109A2 (hu) 2001-04-28
ATE282036T1 (de) 2004-11-15
EP0929544B1 (en) 2004-11-10
DE69731544T2 (de) 2005-10-27
EP0929544A1 (en) 1999-07-21
WO1998011092A1 (en) 1998-03-19
KR20000036111A (ko) 2000-06-26
CA2266015C (en) 2003-12-30
JP2001521489A (ja) 2001-11-06
AU4801197A (en) 1998-04-02
HK1018446A1 (en) 1999-12-24

Similar Documents

Publication Publication Date Title
CN1238770A (zh) 为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物
CN1104427C (zh) 法呢基蛋白转移酶的三环抑制剂
CN100345830C (zh) 稠合杂芳基衍生物
CN1152031C (zh) 具有血管生成抑制活性的异喹啉衍生物
CN1094937C (zh) 具抑制法呢基转化酶作用的喹唑啉酮类
US6277854B1 (en) Tricyclic antitumor farnesyl protein transferase inhibitors
CN1251097A (zh) 具有血管生成抑制活性的酞嗪类化合物
CN1209127A (zh) 三环酰胺类用于抑制g－蛋白功能及治疗增生疾病
CN1155572C (zh) 吲哚类衍生物及其抗肿瘤用途
CN1422269A (zh) 1h－咪唑并吡啶衍生物
CN1294577A (zh) 钾通道抑制剂
CN1324360A (zh) 双环氮杂环
CN1251586A (zh) 新颖嘧啶衍生物及其制法
CN1127498C (zh) 吡啶衍生物、制备吡啶衍生物的方法及其中间体
CN1684951A (zh) 新的嘧啶胺衍生物及其用途
CN1511151A (zh) 3-喹啉-2(1h)-亚基二氢吲哚-2-酮衍生物
CN1250544C (zh) 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法
CN1198158A (zh) 作为酪氨酸激酶抑制剂的双环4－芳烷基氨基嘧啶衍生物
CN1122031C (zh) 用作法呢基蛋白转移酶抑制剂的取代的苯并芳庚并吡啶衍生物
CN1119345C (zh) 用作法呢基蛋白转移酶抑制剂的苯并(5.6)环庚并吡啶化合物
CN1291197A (zh) 新的乙酰胺衍生物及其用途
CN1237169A (zh) 用于抑制g－蛋白功能并用于治疗增生性疾病的三环化合物
CN1237176A (zh) 用作fpt抑制剂的三环化合物
CN1067072C (zh) 三环化合物、它们的制备及其用途
CN1237164A (zh) 用作法呢基－蛋白转移酶抑制剂的化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication